These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 25753245)

  • 21. Novel insights into genetics and clinics of the HNF1A-MODY.
    Valkovicova T; Skopkova M; Stanik J; Gasperikova D
    Endocr Regul; 2019 Apr; 53(2):110-134. PubMed ID: 31517624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Clinical Prediction Model to Distinguish Maturity-Onset Diabetes of the Young From Type 1 and Type 2 Diabetes in the Chinese Population.
    Fu J; Ping F; Wang T; Liu Y; Wang X; Yu J; Deng M; Liu J; Zhang Q; Yu M; Li M; Li Y; Xiao X
    Endocr Pract; 2021 Aug; 27(8):776-782. PubMed ID: 33991656
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apolipoprotein M can discriminate HNF1A-MODY from Type 1 diabetes.
    Mughal SA; Park R; Nowak N; Gloyn AL; Karpe F; Matile H; Malecki MT; McCarthy MI; Stoffel M; Owen KR
    Diabet Med; 2013 Feb; 30(2):246-50. PubMed ID: 23157689
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Should the negativity for islet cell autoantibodies be used in a prescreening for genetic testing in maturity-onset diabetes of the young? The case of autoimmunity-associated destruction of pancreatic β-cells in a family of HNF1A-MODY subjects.
    Urbanová J; Rypáčková B; Kučera P; Anděl M; Heneberg P
    Int Arch Allergy Immunol; 2013; 161(3):279-84. PubMed ID: 23548576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipoprotein composition in HNF1A-MODY: differentiating between HNF1A-MODY and type 2 diabetes.
    McDonald TJ; McEneny J; Pearson ER; Thanabalasingham G; Szopa M; Shields BM; Ellard S; Owen KR; Malecki MT; Hattersley AT; Young IS
    Clin Chim Acta; 2012 May; 413(9-10):927-32. PubMed ID: 22360925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating ghrelin level is higher in HNF1A-MODY and GCK-MODY than in polygenic forms of diabetes mellitus.
    Nowak N; Hohendorff J; Solecka I; Szopa M; Skupien J; Kiec-Wilk B; Mlynarski W; Malecki MT
    Endocrine; 2015 Dec; 50(3):643-9. PubMed ID: 25987348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening of HNF1A and HNF4A mutation and clinical phenotype analysis in a large cohort of Chinese patients with maturity-onset diabetes of the young.
    Wang X; Wang T; Yu M; Zhang H; Ping F; Zhang Q; Xu J; Feng K; Xiao X
    Acta Diabetol; 2019 Mar; 56(3):281-288. PubMed ID: 30293189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence, clinical features and complications of common forms of Maturity Onset Diabetes of the Young (MODY) seen at a tertiary diabetes centre in south India.
    Aarthy R; Aston-Mourney K; Amutha A; Mikocka-Walus A; Anjana RM; Unnikrishnan R; Jebarani S; Venkatesan U; Gopi S; Radha V; Mohan V
    Prim Care Diabetes; 2023 Aug; 17(4):401-407. PubMed ID: 37055265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of HNF1A (MODY3) mutations in a Norwegian population (the HUNT2 Study).
    Eide SA; Raeder H; Johansson S; Midthjell K; Søvik O; Njølstad PR; Molven A
    Diabet Med; 2008 Jul; 25(7):775-81. PubMed ID: 18513305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of an exoglycosidase plate-based assay for detecting α1-3,4 fucosylation biomarker in individuals with HNF1A-MODY.
    Demus D; Urbanowicz PA; Gardner RA; Wu H; Juszczak A; Štambuk T; Medvidović EP; Owen KR; Gornik O; Juge N; Spencer DIR
    Glycobiology; 2022 Mar; 32(3):230-238. PubMed ID: 34939081
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The utility of MODY Probability Calculator in probands of families with early-onset autosomal dominant diabetes from Poland.
    Hohendorff J; Zapala B; Ludwig-Slomczynska AH; Solecka I; Ucieklak D; Matejko B; Mrozinska S; Malecki MT; Szopa M
    Minerva Med; 2019 Dec; 110(6):499-506. PubMed ID: 31638358
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of beta cell and incretin function in patients with MODY1 (HNF4A MODY) and MODY3 (HNF1A MODY) in a Swedish patient collection.
    Ekholm E; Shaat N; Holst JJ
    Acta Diabetol; 2012 Oct; 49(5):349-54. PubMed ID: 21761282
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liver adenomatosis in patients with hepatocyte nuclear factor-1 alpha maturity onset diabetes of the young (HNF1A-MODY): Clinical, radiological and pathological characteristics in a French series.
    Haddouche A; Bellanne-Chantelot C; Rod A; Fournier L; Chiche L; Gautier JF; Timsit J; Laboureau S; Chaillous L; Valero R; Larger E; Jeandidier N; Wilhelm JM; Popelier M; Guillausseau PJ; Thivolet C; Lecomte P; Benhamou PY; Reznik Y
    J Diabetes; 2020 Jan; 12(1):48-57. PubMed ID: 31166087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Can complement factors 5 and 8 and transthyretin be used as biomarkers for MODY 1 (HNF4A-MODY) and MODY 3 (HNF1A-MODY)?
    Karlsson E; Shaat N; Groop L
    Diabet Med; 2008 Jul; 25(7):788-91. PubMed ID: 18513302
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Co-inheritance of HNF1a and GCK mutations in a family with maturity-onset diabetes of the young (MODY): implications for genetic testing.
    López-Garrido MP; Herranz-Antolín S; Alija-Merillas MJ; Giralt P; Escribano J
    Clin Endocrinol (Oxf); 2013 Sep; 79(3):342-7. PubMed ID: 23009393
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating CD36 is reduced in HNF1A-MODY carriers.
    Bacon S; Kyithar MP; Schmid J; Costa Pozza A; Handberg A; Byrne MM
    PLoS One; 2013; 8(9):e74577. PubMed ID: 24069322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Half-Life of Sulfonylureas in HNF1A and HNF4A Human MODY Patients is not Prolonged as Suggested by the Mouse Hnf1a(-/-) Model.
    Urbanova J; Andel M; Potockova J; Klima J; Macek J; Ptacek P; Mat'oska V; Kumstyrova T; Heneberg P
    Curr Pharm Des; 2015; 21(39):5736-48. PubMed ID: 26446475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phenotypical aspects of maturity-onset diabetes of the young (MODY diabetes) in comparison with Type 2 diabetes mellitus (T2DM) in children and adolescents: experience from a large multicentre database.
    Schober E; Rami B; Grabert M; Thon A; Kapellen T; Reinehr T; Holl RW;
    Diabet Med; 2009 May; 26(5):466-73. PubMed ID: 19646184
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of novel variants in the hepatocyte nuclear factor-1alpha gene in South Indian patients with maturity onset diabetes of young.
    Radha V; Ek J; Anuradha S; Hansen T; Pedersen O; Mohan V
    J Clin Endocrinol Metab; 2009 Jun; 94(6):1959-65. PubMed ID: 19336507
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha (HNF1A) and 4 alpha (HNF4A) in maturity-onset diabetes of the young.
    Ellard S; Colclough K
    Hum Mutat; 2006 Sep; 27(9):854-69. PubMed ID: 16917892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.